[Clinical study on 78 cases of testicular tumor].

Seventy eight patients with testicular tumor were treated in our hospital between 1982 and 1992. Of 78 patients, 74 had germinal cell tumor (seminoma in 47 patients and non-seminoma in 27), and the other 4 had 3 malignant lymphoma and 1 rhabdomyosarcoma. Ages ranged from 1 to 67 years with the average of 36.1. The age of the patients with seminoma was significantly higher than that of patients with non-seminoma. Most patients complained of painless swelling of the scrotal content, but some patients complained of testicular pain, fever, and so on. Those who complained of such symptoms had significantly worse prognosis than those who had only painless scrotal swelling. Patients with non-seminoma visited us about 4.9 months after the onset of their symptoms and 12.1 months in seminoma. Clinical stages were more progressive in non-seminoma than in seminoma. Inguinal orchiectomy was performed followed by irradiation, chemotherapy, retroperitoneal lymph node dissection or thoracotomy. Recurrence developed in 6 patients and the other 7 patients died of progressive disease within 2 years from the first attendance. The 2-year survival rate calculated by the Kaplan-Meier method was 81 and 70% in seminoma and non-seminoma, respectively, and 100, 88, 63, 75, and 22% in stage I, IIA, IIB, IIIO and IIIA, B, C, respectively.

[1]  H. Yamanaka,et al.  LIMITATION OF CONVENTIONAL CISPLATINBASED COMBINATION CHEMOTHERAPY FOR DISSEMINATED GERM CELL TUMOR , 1997 .

[2]  P. Wilkinson,et al.  International Germ Cell Consensus Classification: a prognostic factor-based staging system for metastatic germ cell cancers. International Germ Cell Cancer Collaborative Group. , 1997, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[3]  R. Motzer,et al.  High-dose carboplatin, etoposide, and cyclophosphamide for patients with refractory germ cell tumors: treatment results and prognostic factors for survival and toxicity. , 1996, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[4]  L. Einhorn Salvage therapy for germ cell tumors. , 1994, Seminars in oncology.

[5]  R. Mirimanoff,et al.  Prognosis of human chorionic gonadotropin-producing seminoma treated by postoperative radiotherapy. , 1993, International journal of radiation oncology, biology, physics.

[6]  三木 恒治,et al.  Stage I精巣セミノーマに対するsurveillance policyの治療成績の検討 , 1992 .

[7]  M. Gospodarowicz,et al.  Surveillance after orchidectomy for patients with clinical stage I nonseminomatous testis tumors. , 1992, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[8]  D. Radford,et al.  Sarcomatous change in a teratoma after treatment of testicular carcinoma , 1991, Cancer.

[9]  A. Horwich,et al.  Orchidectomy alone for stage I seminoma of the testis , 1990, Cancer.

[10]  L. Einhorn,et al.  Treatment of disseminated germ-cell tumors with cisplatin, bleomycin, and either vinblastine or etoposide. , 1987, The New England journal of medicine.

[11]  S. Fosså,et al.  The diagnostic value of human chorionic gonadotrophin in patients with testicular seminoma. , 1987, British journal of urology.

[12]  A. Horwich,et al.  Surveillance after orchiectomy for stage I seminoma of the testis. , 1987, British journal of urology.

[13]  R. Weiss,et al.  Malignant lymphoma of the testis. , 1986, The American journal of medicine.

[14]  L. Einhorn,et al.  VP-16 plus ifosfamide plus cisplatin as salvage therapy in refractory germ cell cancer. , 1986, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[15]  N. Javadpour,et al.  Prognostic Factors in Non Semin Omatous Testicular Cancer , 1986 .

[16]  L. Einhorn,et al.  Prognostic factors for favorable outcome in disseminated germ cell tumors. , 1986, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[17]  L. Piva,et al.  Cisplatin, etoposide, bleomycin first‐line therapy and early resection of residual tumor in far‐advanced germinal testis cancer , 1985, Cancer.

[18]  M. Keating,et al.  Vascular invasion as a prognosticator of metastatic disease in nonseminomatous germ cell tumors of the testis. Importance in “surveillance only” protocols , 1985, Cancer.

[19]  G. Bosl,et al.  Teratoma with malignant transformation in germ cell tumors in men , 1985, Cancer.

[20]  三木 誠,et al.  1970年代の日本人睾丸(精巣)腫瘍の臨床統計 , 1985 .

[21]  T. Ulbright,et al.  The development of non‐germ cell malignancies within germ cell tumors. A clinicopathologic study of 11 cases , 1984, Cancer.

[22]  A. Horwich,et al.  The treatment of metastatic germ-cell testicular tumours with bleomycin, etoposide and cis-platin (BEP). , 1983, British Journal of Cancer.

[23]  L. Einhorn,et al.  Cis-diamminedichloroplatinum, vinblastine, and bleomycin combination chemotherapy in disseminated testicular cancer. , 1977, Annals of internal medicine.